Brief Description
Drug delivery based on micro-engineering technology utilizing silicon microcapsules with nanofilters so that treatments can be controlled and targeted to particular cells and sites in the body.
The company licensed intellectual property that had been previously licensed to UC Berkeley spinout Iris Micromedical. The IP was developed in the lab of UC Berkeley Associate Professor of Engineering Mauro Ferrari, who moved to Ohio State University in 1999 as a professor of bioengineering, internal medicine, and mechanical engineering. In conjunction with Dr. Ferrari's move to Ohio, Iris Micromedical was reformed as iMedd, Inc.
Timeline
- 1999. iMedd established with operations in both California and Ohio.
Inventors
Wen-Hwa Chu, Peter Dehlinger, Mauro Ferrari, David R. Friend, Carl Grove, Chris Keller, Frank Martin, Bret Megargel, Jay Tu, Yuchun Wang